Sennosides A And B (HERRON SENNESOFT tablet blister pack)
Sennosides A And B risk profile, scheduling, and guidance for claims professionals and care workers . Also known as HERRON SENNESOFT tablet blister pack, AdMed Docu/Senna tablets bottle.
Sennosides A And B (brand names: HERRON SENNESOFT tablet blister pack, AdMed Docu/Senna tablets bottle) is classified as Low risk (1 risk points) by AllMeds. It is a S2 medication under the TGA in Australia. Stimulant laxative with low risk but potential for dependence and electrolyte disturbance.
Key Takeaways
- TGA Schedule: S2 in Australia
- Risk level: Low (1 points)
- Recommended maximum duration: 7 days
Scheduling and Classification
| Jurisdiction | Classification | Status |
|---|---|---|
| Australia (TGA) | S2 | Not PBS listed |
Risk Profile
Stimulant laxative with low risk but potential for dependence and electrolyte disturbance.
Regulatory and Compliance Guidance
When Sennosides A And B appears on a claimant's medication list, claims professionals should assess whether the prescribing is appropriate for the compensable injury, whether the duration is within guidelines, and whether there are interactions with other medications on the claim.
Australia TGA / PBS / State Schemes
Classified as S2 under the Therapeutic Goods Administration (TGA).
Need to assess this medication across your caseload?
Run a full risk assessment including Sennosides A And B interactions and compliance checks.
AllMeds gives you instant risk assessments, compliance checks, and automated letters for every medication on a claim.
No credit card required. No signup for your first 2 questions.
Medical Disclaimer: This content is for informational purposes for claims professionals and care workers. It is not medical advice. Always consult a qualified healthcare professional for clinical decisions. Drug information is sourced from TGA, FDA, MHRA, PBS, NICE, and CDC databases and may not reflect the latest updates. AllMeds does not replace clinical judgement.